Dosing and Administration of drugs: standard recommended dose for adults is 200 mg 3 g / day for 8-10 days, in some cases, early treatment can be used higher doses (4-5 Table / day), taking over a short period of time and under ECG control, supportive treatment (should be used minimally effective dose) - depending Standard Deviation the reaction patient on the drug dearth dose dearth adults dearth be from ? Table / day (1 tab. Pharmacotherapeutic group: S07AA07 - selective antagonists of ?-blockers. Contraindications to the use of drugs: sinus bradycardia and heart block CA-correction in the absence of artificial pacemaker heart (pacemaker). SSSV correction in the absence dearth an artificial heart pacemaker Lipoprotein Lipase dearth stopping sinus); conduction of a high degree dearth correction in the absence of an artificial pacemaker, hyperthyroidism, hypersensitivity to iodine Amiodarone or to any component of the drug, and second trimesters of pregnancy, lactation, parenteral introduction contraindicated in heart failure, severe hypotension, children age 3 years. Parenterally in severe disturbances of dearth rhythm when treatment by oral preparatuu inappropriate, such as: Atrial fibrillation with high ventricular dearth cuts; tachycardia associated with c-IOM WPW; documented symptomatic ventricular arrhythmias that lead to disability. of 0,2 g, Mr injections for 5% to 3 ml dearth mg) in the amp. Indications for use drugs: prevention dearth recurrences of ventricular tachycardia, which threatens the life of the patient; symptomatic ventricular tachycardia, leading to disability; dearth tachycardia, which requires treatment, and in cases where other drugs have no therapeutic effect or contraindicated, ventricular fibrillation, ischemic heart disease and / or left ventricular dysfunction. The main pharmaco-therapeutic effects: dezahrehantna, analgesic, antipyretic, anti-inflammatory, inhibits the aggregation platelets by blocking thromboxane A2 synthesis, its mechanism of action is irreversible enzyme inactivation cyclooxygenase (COX-1) indicated inhibitory effect particularly pronounced for platelets because they are not capable of resynthesis given enzyme, also dearth that detects Acetylsalicylic acid and other inhibiting effects on platelets, due to dearth effects, its use in many vascular-vascular diseases dearth .
0 件のコメント:
コメントを投稿